Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$6.25.

  • Onconetix's EPS (Basic) rose 9749.08% to -$6.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $3049.1, marking a year-over-year increase of 22140.24%. This contributed to the annual value of -$21.45 for FY2024, which is 7546.96% up from last year.
  • Latest data reveals that Onconetix reported EPS (Basic) of -$6.25 as of Q3 2025, which was up 9749.08% from -$4.76 recorded in Q2 2025.
  • In the past 5 years, Onconetix's EPS (Basic) ranged from a high of -$0.18 in Q1 2023 and a low of -$2191.6 during Q2 2024
  • Over the past 3 years, Onconetix's median EPS (Basic) value was -$10.8 (recorded in 2024), while the average stood at -$231.65.
  • In the last 5 years, Onconetix's EPS (Basic) plummeted by 50957209.3% in 2024 and then soared by 9978.29% in 2025.
  • Quarter analysis of 3 years shows Onconetix's EPS (Basic) stood at -$52.25 in 2023, then skyrocketed by 79.33% to -$10.8 in 2024, then soared by 42.12% to -$6.25 in 2025.
  • Its EPS (Basic) stands at -$6.25 for Q3 2025, versus -$4.76 for Q2 2025 and -$0.53 for Q1 2025.